Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 30;12(6):780-790.
doi: 10.21037/gs-22-469. Epub 2023 Jun 12.

Application of fluorescence endoscopy with methylene blue dye and indocyanine green dual-tracer method in sentinel lymph node biopsy for women with breast cancer

Caifeng Ou  1   2 , Yunfeng Luo  1 , Linyun He  1 , Di Zhu  1 , Yanwen Zhu  1 , Qianyun Chen  1 , Xirui Xu  1 , Pusheng Zhang  1
Affiliations

Application of fluorescence endoscopy with methylene blue dye and indocyanine green dual-tracer method in sentinel lymph node biopsy for women with breast cancer

Caifeng Ou et al. Gland Surg. .

Abstract

Background: Indocyanine green (ICG) allows for the real-time visualization of lymphatic drainage and provides favorable performance for sentinel lymph node (SLN) mapping. However, the limited ability of tissue penetration of the near-infrared fluorescence of ICG may lead to the failure of lymph node detection in the traditional open approach of sentinel lymph node biopsy (SLNB) for breast cancer, especially in overweight or obese patients. To accurately and quickly detect SLNs, we applied fluorescence endoscopy with a dual-tracer method using ICG and methylene blue dye (MBD) in SLNB for breast cancer. We conducted this study to assess the feasibility and application value of this method in minimally invasive surgery.

Methods: A total of 117 patients who received dual-tracer injection of ICG and MBD prior to endoscopic SLNB from November 2020 to September 2021 were examined in this study. The number of SLNs identified, the SLN identification rate, the time to identify the first SLN, the procedure duration, and the postoperative morbidity were analyzed.

Results: Biopsied SLNs could be identified in 116 patients (99.15%) with an average number of 5.12±1.87 per patient. Blue-stained SLNs were found in 99 patients (84.62%) and fluorescent SLNs in 112 patients (95.73%). A total of 34 patients (29.06%) had positive SLNs. In 6 cases (5.13%), the positive SLNs were only stained with ICG fluorescence. In 1 case (0.85%), the positive SLNs were only blue-stained with no fluorescence staining. The mean durations for the identification of the first SLN and endoscopic SLNB were 7.14±6.31 and 37.75±16.94 min, respectively. Upper-limb lymphoedema was observed 5 cases (4.27%) during a median follow-up period of 10 months.

Conclusions: The fluorescence endoscopy method assisted by dual tracer facilitates SLN detection with a comparatively short procedure duration and low complication rate. This approach could serve as a new method for SLNB for patients with breast cancer.

Keywords: Indocyanine green (ICG); breast neoplasms; fluorescence endoscopy; methylene blue dye (MBD); sentinel lymph node biopsy (SLNB).

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://gs.amegroups.com/article/view/10.21037/gs-22-469/coif). The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Injection sites of methylene blue dye and indocyanine green (arrows).
Figure 2
Figure 2
Visualization of lymphatic flows (arrows) to the axilla under different modes of a high-definition fluorescence endoscope. (A) “Standard” white-light mode. (B) “Standard” fluorescence mode. (C) Multi-display mode. (D) Pseudo-color fluorescence mode.
Figure 3
Figure 3
Creation of the area of surgical exploration and operating space. (A) A balloon made from sterile gloves was connected to a drainage tube and syringe. (B) Physiologic (0.9%) saline was injected into the balloon to separate subcutaneous tissues and expand the tunnel.
Figure 4
Figure 4
Representative images of sentinel lymph node detection using fluorescence endoscopy. Blue-stained and fluorescent lymphatic vessels and lymph nodes (arrows) were visible simultaneously in the multi-display mode.
Figure 5
Figure 5
Representative images of resected sentinel lymph nodes. One of four sentinel lymph nodes were blue-stained, and indocyanine green fluorescence was observed in all detected sentinel lymph nodes.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. International Agency for Research on Cancer. World Cancer Day: Breast cancer overtakes lung cancer in terms of number of new cancer cases worldwide. IARC showcases key research projects to address breast cancer. Lyon, France. Available online: www.iarc.who.int/pressrelease/
    1. Brackstone M, Baldassarre FG, Perera FE, et al. Management of the Axilla in Early-Stage Breast Cancer: Ontario Health (Cancer Care Ontario) and ASCO Guideline. J Clin Oncol 2021;39:3056-82. 10.1200/JCO.21.00934 - DOI - PubMed
    1. Straver ME, Meijnen P, van Tienhoven G, et al. Sentinel node identification rate and nodal involvement in the EORTC 10981-22023 AMAROS trial. Ann Surg Oncol 2010;17:1854-61. 10.1245/s10434-010-0945-z - DOI - PMC - PubMed
    1. Ahmed M, Purushotham AD, Douek M. Novel techniques for sentinel lymph node biopsy in breast cancer: a systematic review. Lancet Oncol 2014;15:e351-62. 10.1016/S1470-2045(13)70590-4 - DOI - PubMed
    1. Baeten IGT, Hoogendam JP, Braat AJAT, et al. Fluorescent Indocyanine Green versus Technetium-99m and Blue Dye for Bilateral SENTinel Lymph Node Detection in Stage I-IIA Cervical Cancer (FluoreSENT): protocol for a non-inferiority study. BMJ Open 2022;12:e061829. 10.1136/bmjopen-2022-061829 - DOI - PMC - PubMed